恒烁股份(688416) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥80,512,216.44, representing a year-on-year increase of 12.23%[5] - The net profit attributable to shareholders was -¥33,053,294.05, indicating a significant loss compared to the previous year[5] - The net cash flow from operating activities was -¥29,987,875.84, reflecting ongoing cash flow challenges[5] - Total revenue for Q1 2024 was CNY 80,512,216.44, an increase of 12.4% compared to CNY 71,737,051.90 in Q1 2023[19] - Net loss for Q1 2024 was CNY 33,053,294.05, compared to a net loss of CNY 18,674,066.37 in Q1 2023, indicating a deterioration in profitability[20] - Basic and diluted earnings per share for Q1 2024 were both CNY -0.40, compared to CNY -0.23 in Q1 2023[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,602,935,870.89, down 3.26% from the end of the previous year[6] - Total assets decreased to CNY 1,602,935,870.89 in Q1 2024 from CNY 1,657,008,240.42 in Q1 2023, a decline of 3.3%[18] - Total liabilities decreased to CNY 105,999,476.92 in Q1 2024 from CNY 128,300,640.81 in Q1 2023, a reduction of 17.3%[18] - The equity attributable to shareholders decreased by 2.08% to ¥1,496,936,393.97 compared to the previous year[6] Cash Flow - The net cash inflow from operating activities was -$29,987,875.84, an improvement from -$42,435,072.15 in the previous year, indicating a 29.5% reduction in cash outflow[24] - Total cash inflow from operating activities was $108,462,454.50, compared to $96,439,087.14 in the previous year, indicating a 12.5% increase[24] - Cash and cash equivalents increased to RMB 268,721,643.26 from RMB 216,822,911.57, representing a growth of about 23.9%[16] - The cash and cash equivalents at the end of the period totaled $268,721,643.26, down from $689,671,440.99 in the previous year, reflecting a 61.0% decrease[25] Research and Development - Research and development expenses totaled ¥18,111,923.25, accounting for 22.50% of operating revenue, a decrease of 3.48 percentage points from the previous year[6] - Research and development expenses for Q1 2024 were CNY 18,111,923.25, slightly down from CNY 18,637,832.38 in Q1 2023[20] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,881[11] - The company has a significant shareholder structure, with XIANGDONG LU holding 13.10% and LU Yinan holding 8.31%, together controlling 29.64% of the company[13] Other Information - The company’s financial statements are unaudited for the first quarter of 2024[15] - The company has not disclosed any new product developments or market expansion strategies in the current report[14] - There are no significant reminders or additional important information regarding the company's operational status during the reporting period[14] - The company has implemented new accounting standards starting in 2024, which may affect financial reporting going forward[25]